speb/financial-data huggingface dataset:
PLRX income_statement (annual, 2023-12-31) — Interest Income Non Operating: 24076000.00
PLRX cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 1149000.00
PLRX balance_sheet (annual, 2023-12-31) — Invested Capital: 483630000.00
PLRX cash_flow (annual, 2023-12-31) — Investing Cash Flow: -127012000.00
PLRX cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 275252000.00
PLRX cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
PLRX balance_sheet (annual, 2023-12-31) — Leases: 1663000.00
PLRX balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 0.00
PLRX balance_sheet (annual, 2023-12-31) — Long Term Debt: 10054000.00
PLRX balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 10054000.00
PLRX cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
PLRX balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 124000.00
PLRX cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 275252000.00
PLRX income_statement (annual, 2023-12-31) — Net Income: -161336000.00
PLRX income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -161336000.00
PLRX income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -161336000.00
PLRX income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -161336000.00
PLRX income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -161336000.00
PLRX cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -161336000.00
PLRX income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -161336000.00
PLRX income_statement (annual, 2023-12-31) — Net Interest Income: 22809000.00
PLRX cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -126091000.00
PLRX cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 0.00
PLRX cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 0.00
PLRX income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 22809000.00
PLRX cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -847000.00
PLRX balance_sheet (annual, 2023-12-31) — Net PPE: 4778000.00
PLRX cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -921000.00
PLRX balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 473576000.00
PLRX income_statement (annual, 2023-12-31) — Normalized EBITDA: -158228000.00
PLRX income_statement (annual, 2023-12-31) — Normalized Income: -161336000.00
PLRX cash_flow (annual, 2023-12-31) — Operating Cash Flow: -116361000.00
PLRX income_statement (annual, 2023-12-31) — Operating Income: -184145000.00
PLRX income_statement (annual, 2023-12-31) — Operating Revenue: 1580000.00
PLRX balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 59921002.00
PLRX balance_sheet (annual, 2023-12-31) — Other Current Assets: 1272000.00
PLRX balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 345000.00
PLRX income_statement (annual, 2023-12-31) — Other Gand A: 57928000.00
PLRX cash_flow (annual, 2023-12-31) — Other Non Cash Items: 2390000.00
PLRX balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 1874000.00
PLRX balance_sheet (annual, 2023-12-31) — Other Properties: 11621000.00
PLRX balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 431011000.00
PLRX balance_sheet (annual, 2023-12-31) — Payables: 4531000.00
PLRX balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 18164000.00
PLRX balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 9042000.00
PLRX balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
PLRX balance_sheet (annual, 2023-12-31) — Prepaid Assets: 6988000.00
PLRX income_statement (annual, 2023-12-31) — Pretax Income: -161336000.00
PLRX balance_sheet (annual, 2023-12-31) — Properties: 0.00
PLRX cash_flow (annual, 2023-12-31) — Purchase Of Investment: -583069000.00
PLRX cash_flow (annual, 2023-12-31) — Purchase Of PPE: -921000.00
PLRX balance_sheet (annual, 2023-12-31) — Receivables: 2997000.00
PLRX income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1841000.00
PLRX income_statement (annual, 2023-12-31) — Research And Development: 127797000.00
PLRX balance_sheet (annual, 2023-12-31) — Retained Earnings: -499748000.00
PLRX cash_flow (annual, 2023-12-31) — Sale Of Investment: 456978000.00
PLRX income_statement (annual, 2023-12-31) — Selling General And Administration: 57928000.00
PLRX balance_sheet (annual, 2023-12-31) — Share Issued: 59921002.00
PLRX cash_flow (annual, 2023-12-31) — Stock Based Compensation: 44483000.00
PLRX balance_sheet (annual, 2023-12-31) — Stockholders Equity: 473576000.00
PLRX balance_sheet (annual, 2023-12-31) — Tangible Book Value: 473576000.00
PLRX income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
PLRX income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
PLRX balance_sheet (annual, 2023-12-31) — Taxes Receivable: 0.00
PLRX balance_sheet (annual, 2023-12-31) — Total Assets: 512154000.00
PLRX balance_sheet (annual, 2023-12-31) — Total Capitalization: 483630000.00
PLRX balance_sheet (annual, 2023-12-31) — Total Debt: 11372000.00
PLRX balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 473576000.00
PLRX income_statement (annual, 2023-12-31) — Total Expenses: 185725000.00
PLRX balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 38578000.00
PLRX balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 6652000.00
PLRX balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 10054000.00
PLRX income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -184145000.00
PLRX balance_sheet (annual, 2023-12-31) — Working Capital: 476978000.00
PLRX cash_flow (quarterly, 2024-09-30) — Capital Expenditure: -896000.00
PLRX cash_flow (quarterly, 2024-09-30) — Change In Receivables: 0.00
PLRX cash_flow (quarterly, 2024-09-30) — Changes In Account Receivables: 0.00
PLRX cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 543000.00
PLRX cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 543000.00
PLRX balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 30139000.00
PLRX cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 543000.00
PLRX income_statement (annual, 2024-12-31) — +Operating Expense: 228365000.00
PLRX income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
PLRX balance_sheet (annual, 2024-12-31) — Accounts Payable: 5960000.00
PLRX balance_sheet (annual, 2024-12-31) — Accrued Interest Receivable: 2302000.00
PLRX balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -10807000.00
PLRX balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1013806000.00
PLRX cash_flow (annual, 2024-12-31) — Amortization Of Securities: 2510000.00
PLRX balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 0.00
PLRX balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 0.00
PLRX income_statement (annual, 2024-12-31) — Basic Average Shares: 60538639.00
PLRX income_statement (annual, 2024-12-31) — Basic EPS: -3.47
PLRX cash_flow (annual, 2024-12-31) — Beginning Cash Position: 64716000.00
PLRX cash_flow (annual, 2024-12-31) — Capital Expenditure: -3848000.00
PLRX cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -209000.00
PLRX balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 29981000.00
PLRX balance_sheet (annual, 2024-12-31) — Capital Stock: 6000.00
PLRX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 71188000.00
PLRX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 355724000.00
PLRX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 23117000.00
PLRX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 140340000.00
PLRX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -155503000.00
PLRX cash_flow (annual, 2024-12-31) — Change In Account Payable: 1428000.00
PLRX cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 3807000.00
PLRX cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -43000.00
PLRX cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -820000.00
PLRX cash_flow (annual, 2024-12-31) — Change In Payable: 1428000.00
PLRX cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 5235000.00
PLRX cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 4717000.00
PLRX cash_flow (annual, 2024-12-31) — Change In Receivables: 0.00
PLRX cash_flow (quarterly, 2024-12-31) — Change In Receivables: 0.00
PLRX cash_flow (annual, 2024-12-31) — Change In Working Capital: 9089000.00
PLRX cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 0.00
PLRX cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: 0.00
PLRX cash_flow (annual, 2024-12-31) — Changes In Cash: 7954000.00
PLRX balance_sheet (annual, 2024-12-31) — Common Stock: 6000.00
PLRX balance_sheet (annual, 2024-12-31) — Common Stock Equity: 304081000.00
PLRX cash_flow (annual, 2024-12-31) — Common Stock Issuance: 3207000.00
PLRX cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 101000.00
PLRX balance_sheet (annual, 2024-12-31) — Construction In Progress: 346000.00
PLRX balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 15562000.00
PLRX balance_sheet (annual, 2024-12-31) — Current Assets: 362264000.00
PLRX balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 542000.00
PLRX balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 542000.00
PLRX balance_sheet (annual, 2024-12-31) — Current Liabilities: 33218000.00
PLRX cash_flow (annual, 2024-12-31) — Depreciation: 2125000.00
PLRX cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 2125000.00
PLRX cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 2125000.00
PLRX income_statement (annual, 2024-12-31) — Diluted Average Shares: 60538639.00
PLRX income_statement (annual, 2024-12-31) — Diluted EPS: -3.47
PLRX income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -210304000.00
PLRX income_statement (annual, 2024-12-31) — EBIT: -207280000.00
PLRX income_statement (annual, 2024-12-31) — EBITDA: -205155000.00
PLRX cash_flow (annual, 2024-12-31) — End Cash Position: 72670000.00
PLRX cash_flow (annual, 2024-12-31) — Financing Cash Flow: 23117000.00
PLRX cash_flow (annual, 2024-12-31) — Free Cash Flow: -159351000.00
PLRX cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
PLRX balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 321000.00
PLRX income_statement (annual, 2024-12-31) — General And Administrative Expense: 59055000.00
PLRX balance_sheet (annual, 2024-12-31) — Gross PPE: 43575000.00
PLRX income_statement (annual, 2024-12-31) — Interest Expense: 3024000.00
PLRX income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 3024000.00
PLRX income_statement (annual, 2024-12-31) — Interest Income: 21085000.00
PLRX income_statement (annual, 2024-12-31) — Interest Income Non Operating: 21085000.00
PLRX cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 2620000.00
PLRX balance_sheet (annual, 2024-12-31) — Invested Capital: 334292000.00
PLRX cash_flow (annual, 2024-12-31) — Investing Cash Flow: 140340000.00
PLRX cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 3207000.00
PLRX cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 101000.00
PLRX cash_flow (annual, 2024-12-31) — Issuance Of Debt: 19910000.00
PLRX cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 1000.00
PLRX balance_sheet (annual, 2024-12-31) — Leases: 2118000.00
PLRX balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 29439000.00
PLRX balance_sheet (annual, 2024-12-31) — Long Term Debt: 30211000.00
PLRX balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 30211000.00
PLRX balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 59650000.00
PLRX cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 19910000.00
PLRX cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 1000.00
PLRX cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
PLRX balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 2880000.00
PLRX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 3207000.00
PLRX cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 101000.00
PLRX income_statement (annual, 2024-12-31) — Net Income: -210304000.00
PLRX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -210304000.00
PLRX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -210304000.00
PLRX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -210304000.00
PLRX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -210304000.00
PLRX cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -210304000.00
PLRX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -210304000.00
PLRX income_statement (annual, 2024-12-31) — Net Interest Income: 18061000.00
PLRX cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 144188000.00
PLRX cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 19910000.00
PLRX cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 1000.00
PLRX cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 19910000.00
PLRX cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 1000.00
PLRX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 18061000.00
PLRX balance_sheet (annual, 2024-12-31) — Net PPE: 32768000.00
PLRX cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -3848000.00
PLRX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 304081000.00
PLRX income_statement (annual, 2024-12-31) — Normalized EBITDA: -205155000.00
PLRX income_statement (annual, 2024-12-31) — Normalized Income: -210304000.00
PLRX cash_flow (annual, 2024-12-31) — Operating Cash Flow: -155503000.00
PLRX income_statement (annual, 2024-12-31) — Operating Income: -228365000.00
PLRX income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
PLRX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 60860838.00
PLRX balance_sheet (annual, 2024-12-31) — Other Current Assets: 163000.00
PLRX balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 321000.00
PLRX income_statement (annual, 2024-12-31) — Other Gand A: 59055000.00
PLRX cash_flow (annual, 2024-12-31) — Other Non Cash Items: 3451000.00
PLRX balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 1917000.00
PLRX balance_sheet (annual, 2024-12-31) — Other Properties: 38231000.00
PLRX balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 284536000.00
PLRX balance_sheet (annual, 2024-12-31) — Payables: 5960000.00
PLRX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 21522000.00
PLRX balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 11154000.00
PLRX balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
PLRX balance_sheet (annual, 2024-12-31) — Prepaid Assets: 4075000.00
PLRX income_statement (annual, 2024-12-31) — Pretax Income: -210304000.00
PLRX balance_sheet (annual, 2024-12-31) — Properties: 0.00
PLRX cash_flow (annual, 2024-12-31) — Purchase Of Investment: -211285000.00
PLRX cash_flow (annual, 2024-12-31) — Purchase Of PPE: -3848000.00
PLRX balance_sheet (annual, 2024-12-31) — Receivables: 2302000.00
PLRX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 2125000.00
PLRX cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
PLRX income_statement (annual, 2024-12-31) — Research And Development: 169310000.00
PLRX balance_sheet (annual, 2024-12-31) — Retained Earnings: -710052000.00
PLRX cash_flow (annual, 2024-12-31) — Sale Of Investment: 355473000.00
PLRX cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
PLRX income_statement (annual, 2024-12-31) — Selling General And Administration: 59055000.00
PLRX balance_sheet (annual, 2024-12-31) — Share Issued: 60860838.00
PLRX income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
PLRX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 37626000.00
PLRX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 304081000.00
PLRX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 304081000.00
PLRX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
PLRX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
PLRX balance_sheet (annual, 2024-12-31) — Total Assets: 396949000.00
PLRX balance_sheet (annual, 2024-12-31) — Total Capitalization: 334292000.00
PLRX balance_sheet (annual, 2024-12-31) — Total Debt: 60192000.00
PLRX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 304081000.00
PLRX income_statement (annual, 2024-12-31) — Total Expenses: 228365000.00
PLRX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 92868000.00
PLRX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 34685000.00
PLRX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 59650000.00
PLRX income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -228365000.00
PLRX income_statement (annual, 2024-12-31) — Total Unusual Items: 0.00
PLRX income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
PLRX balance_sheet (annual, 2024-12-31) — Working Capital: 329046000.00
PLRX income_statement (quarterly, 2025-03-31) — +Operating Expense: 58935000.00
PLRX income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
PLRX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 5622000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Accrued Interest Receivable: 1683000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -11255000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1023217000.00
PLRX cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: 1362000.00
PLRX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 61222676.00
PLRX income_statement (quarterly, 2025-03-31) — Basic EPS: -0.92
PLRX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 72670000.00
PLRX cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -262000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 29890000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 6000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 91936000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 305645000.00
PLRX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 498000.00
PLRX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 69114000.00
PLRX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -48864000.00
PLRX cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -338000.00
PLRX cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -4808000.00
PLRX cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 8000.00
PLRX cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -91000.00
PLRX cash_flow (quarterly, 2025-03-31) — Change In Payable: -338000.00
PLRX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -5146000.00
PLRX cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 995000.00
PLRX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -4234000.00
PLRX cash_flow (quarterly, 2025-03-31) — Changes In Cash: 20748000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Common Stock: 6000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 257164000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 134000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 16424000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Current Assets: 311191000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 771000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 771000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 28203000.00
PLRX cash_flow (quarterly, 2025-03-31) — Depreciation: 448000.00
PLRX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 448000.00
PLRX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 448000.00
PLRX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 61222676.00
PLRX income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.92
PLRX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -56166000.00
PLRX income_statement (quarterly, 2025-03-31) — EBIT: -55367000.00
PLRX income_statement (quarterly, 2025-03-31) — EBITDA: -54919000.00
PLRX cash_flow (quarterly, 2025-03-31) — End Cash Position: 93418000.00
PLRX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 498000.00
PLRX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -49126000.00
PLRX cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
PLRX balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 159000.00
PLRX income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 15499000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 42925000.00
PLRX income_statement (quarterly, 2025-03-31) — Interest Expense: 799000.00
PLRX income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 799000.00
PLRX income_statement (quarterly, 2025-03-31) — Interest Income: 3568000.00
PLRX income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 3568000.00
PLRX cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 723000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 287448000.00
PLRX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 69114000.00
PLRX cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
PLRX balance_sheet (quarterly, 2025-03-31) — Leases: 2118000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 29119000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 30284000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 59403000.00
PLRX cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
PLRX balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 2937000.00
PLRX income_statement (quarterly, 2025-03-31) — Net Income: -56166000.00
PLRX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -56166000.00
PLRX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -56166000.00
PLRX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -56166000.00
PLRX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -56166000.00
PLRX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -56166000.00
PLRX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -56166000.00
PLRX income_statement (quarterly, 2025-03-31) — Net Interest Income: 2769000.00
PLRX cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 69376000.00
PLRX cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
PLRX cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 0.00
PLRX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 2769000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Net PPE: 31670000.00
PLRX cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -262000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 257164000.00
PLRX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -54919000.00
PLRX income_statement (quarterly, 2025-03-31) — Normalized Income: -56166000.00
PLRX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -48864000.00
PLRX income_statement (quarterly, 2025-03-31) — Operating Income: -58935000.00
PLRX income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
PLRX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 61386183.00
PLRX balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 57000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 159000.00
PLRX income_statement (quarterly, 2025-03-31) — Other Gand A: 15499000.00
PLRX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 813000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1909000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Other Properties: 37736000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 213709000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Payables: 5622000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 22046000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 5386000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
PLRX balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 3806000.00
PLRX income_statement (quarterly, 2025-03-31) — Pretax Income: -56166000.00
PLRX cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 498000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
PLRX cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -14149000.00
PLRX cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -262000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Receivables: 1683000.00
PLRX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 448000.00
PLRX income_statement (quarterly, 2025-03-31) — Research And Development: 43436000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -766218000.00
PLRX cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 83525000.00
PLRX cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
PLRX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 15499000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Share Issued: 61386183.00
PLRX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 8913000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 257164000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 257164000.00
PLRX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
PLRX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
PLRX balance_sheet (quarterly, 2025-03-31) — Total Assets: 344770000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 287448000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Total Debt: 60174000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 257164000.00
PLRX income_statement (quarterly, 2025-03-31) — Total Expenses: 58935000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 87606000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 33579000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 59403000.00
PLRX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -58935000.00
PLRX balance_sheet (quarterly, 2025-03-31) — Working Capital: 282988000.00
PLRX income_statement (quarterly, 2025-06-30) — +Operating Expense: 45592000.00
PLRX income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
PLRX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1384000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Accrued Interest Receivable: 1535000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -11702000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1029595000.00
PLRX cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: 1977000.00
PLRX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 61386183.00
PLRX income_statement (quarterly, 2025-06-30) — Basic EPS: -0.71
PLRX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 93418000.00
PLRX cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -112000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 30016000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 6000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 86820000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 262873000.00
PLRX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 0.00
PLRX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 35487000.00
PLRX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -40603000.00
PLRX cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -4242000.00
PLRX cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -3814000.00
PLRX cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 35000.00
PLRX cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 126000.00
PLRX cash_flow (quarterly, 2025-06-30) — Change In Payable: -4242000.00
PLRX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -8056000.00
PLRX cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 975000.00
PLRX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -6920000.00
PLRX cash_flow (quarterly, 2025-06-30) — Changes In Cash: -5116000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Common Stock: 6000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 220082000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 153000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 11749000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Current Assets: 267444000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 1225000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1225000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 20591000.00
PLRX cash_flow (quarterly, 2025-06-30) — Depreciation: 447000.00
PLRX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 447000.00
PLRX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 447000.00
PLRX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 61386183.00
PLRX income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.71
PLRX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -43300000.00
PLRX income_statement (quarterly, 2025-06-30) — EBIT: -42491000.00
PLRX income_statement (quarterly, 2025-06-30) — EBITDA: -42044000.00
PLRX cash_flow (quarterly, 2025-06-30) — End Cash Position: 88302000.00
PLRX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 0.00
PLRX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -40715000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -1000.00
PLRX income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 13394000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 42209000.00
PLRX income_statement (quarterly, 2025-06-30) — Interest Expense: 809000.00
PLRX income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 809000.00
PLRX income_statement (quarterly, 2025-06-30) — Interest Income: 3101000.00
PLRX income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 3101000.00
PLRX cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 734000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 250442000.00
PLRX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 35487000.00
PLRX cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
PLRX balance_sheet (quarterly, 2025-06-30) — Leases: 2156000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 28791000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 30360000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 59151000.00
PLRX cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
PLRX balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 2936000.00
PLRX income_statement (quarterly, 2025-06-30) — Net Income: -43300000.00
PLRX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -43300000.00
PLRX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -43300000.00
PLRX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -43300000.00
PLRX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -43300000.00
PLRX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -43300000.00
PLRX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -43300000.00
PLRX income_statement (quarterly, 2025-06-30) — Net Interest Income: 2292000.00
PLRX cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 35599000.00
PLRX cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 0.00
PLRX cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 0.00
PLRX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 2292000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Net PPE: 30507000.00
PLRX cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -112000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 220082000.00
PLRX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -42044000.00
PLRX income_statement (quarterly, 2025-06-30) — Normalized Income: -43300000.00
PLRX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -40603000.00
PLRX income_statement (quarterly, 2025-06-30) — Operating Income: -45592000.00
PLRX income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
PLRX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 61386183.00
PLRX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 75000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -1000.00
PLRX income_statement (quarterly, 2025-06-30) — Other Gand A: 13394000.00
PLRX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 815000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 1873000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Other Properties: 36964000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 176053000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Payables: 1384000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 13133000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 6233000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
PLRX balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 2961000.00
PLRX income_statement (quarterly, 2025-06-30) — Pretax Income: -43300000.00
PLRX cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
PLRX balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
PLRX cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -51607000.00
PLRX cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -112000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Receivables: 1535000.00
PLRX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 447000.00
PLRX income_statement (quarterly, 2025-06-30) — Research And Development: 32198000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -809518000.00
PLRX cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 87206000.00
PLRX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 13394000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Share Issued: 61386183.00
PLRX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 6378000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 220082000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 220082000.00
PLRX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
PLRX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
PLRX balance_sheet (quarterly, 2025-06-30) — Total Assets: 299824000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 250442000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Total Debt: 60376000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 220082000.00
PLRX income_statement (quarterly, 2025-06-30) — Total Expenses: 45592000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 79742000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 32380000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 59151000.00
PLRX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -45592000.00
PLRX balance_sheet (quarterly, 2025-06-30) — Working Capital: 246853000.00
PLRX income_statement (quarterly, 2025-09-30) — +Operating Expense: 28269000.00
PLRX income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
PLRX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 485000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Accrued Interest Receivable: 908000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -12034000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1036085000.00
PLRX cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: 335000.00
PLRX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 61406475.00
PLRX income_statement (quarterly, 2025-09-30) — Basic EPS: -0.43
PLRX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 88302000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 29418000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 6000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 93732000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 241797000.00
PLRX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 72000.00
PLRX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 27921000.00
PLRX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -21081000.00
PLRX cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -897000.00
PLRX cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -2031000.00
PLRX cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 0.00
PLRX cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -598000.00
PLRX cash_flow (quarterly, 2025-09-30) — Change In Payable: -897000.00
PLRX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -2928000.00
PLRX cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 780000.00
PLRX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -2746000.00
PLRX cash_flow (quarterly, 2025-09-30) — Changes In Cash: 6912000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Common Stock: 6000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 200306000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 154000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 9001000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Current Assets: 245588000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1187000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1187000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 17624000.00
PLRX cash_flow (quarterly, 2025-09-30) — Depreciation: 436000.00
PLRX cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 436000.00
PLRX cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 436000.00
PLRX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 61406475.00
PLRX income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.43
PLRX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -26301000.00
PLRX income_statement (quarterly, 2025-09-30) — EBIT: -25486000.00
PLRX income_statement (quarterly, 2025-09-30) — EBITDA: -25050000.00
PLRX cash_flow (quarterly, 2025-09-30) — End Cash Position: 95214000.00
PLRX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 72000.00
PLRX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -21081000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 34000.00
PLRX income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 10331000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Gross PPE: 41172000.00
PLRX income_statement (quarterly, 2025-09-30) — Interest Expense: 815000.00
PLRX income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 815000.00
PLRX income_statement (quarterly, 2025-09-30) — Interest Income: 2783000.00
PLRX income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 2783000.00
PLRX cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 735000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 230745000.00
PLRX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 27921000.00
PLRX cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
PLRX balance_sheet (quarterly, 2025-09-30) — Leases: 2156000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 28231000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 30439000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 58670000.00
PLRX cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
PLRX balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 2936000.00
PLRX income_statement (quarterly, 2025-09-30) — Net Income: -26301000.00
PLRX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -26301000.00
PLRX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -26301000.00
PLRX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -26301000.00
PLRX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -26301000.00
PLRX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -26301000.00
PLRX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -26301000.00
PLRX income_statement (quarterly, 2025-09-30) — Net Interest Income: 1968000.00
PLRX cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 27765000.00
PLRX cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
PLRX cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
PLRX income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 1968000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Net PPE: 29138000.00
PLRX cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 156000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 200306000.00
PLRX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -25050000.00
PLRX income_statement (quarterly, 2025-09-30) — Normalized Income: -26301000.00
PLRX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -21081000.00
PLRX income_statement (quarterly, 2025-09-30) — Operating Income: -28269000.00
PLRX income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
PLRX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 61449290.00
PLRX balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 75000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 34000.00
PLRX income_statement (quarterly, 2025-09-30) — Other Gand A: 10331000.00
PLRX cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 821000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 1874000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Other Properties: 35926000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 148065000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Payables: 485000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 9486000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 6951000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
PLRX balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 2808000.00
PLRX income_statement (quarterly, 2025-09-30) — Pretax Income: -26301000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
PLRX cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -52563000.00
PLRX cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 0.00
PLRX balance_sheet (quarterly, 2025-09-30) — Receivables: 908000.00
PLRX income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 436000.00
PLRX income_statement (quarterly, 2025-09-30) — Research And Development: 17938000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -835819000.00
PLRX cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 80328000.00
PLRX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 10331000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Share Issued: 61449290.00
PLRX cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 6418000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 200306000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 200306000.00
PLRX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
PLRX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
PLRX balance_sheet (quarterly, 2025-09-30) — Total Assets: 276600000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 230745000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Total Debt: 59857000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 200306000.00
PLRX income_statement (quarterly, 2025-09-30) — Total Expenses: 28269000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 76294000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 31012000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 58670000.00
PLRX income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -28269000.00
PLRX balance_sheet (quarterly, 2025-09-30) — Working Capital: 227964000.00
PLRX income_statement (annual, 2025-12-31) — +Operating Expense: 156373000.00
PLRX income_statement (quarterly, 2025-12-31) — +Operating Expense: 23577000.00
PLRX income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
PLRX income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
PLRX balance_sheet (annual, 2025-12-31) — Accounts Payable: 480000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 480000.00
PLRX balance_sheet (annual, 2025-12-31) — Accrued Interest Receivable: 823000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Accrued Interest Receivable: 823000.00
PLRX balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -10869000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -10869000.00
PLRX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1040610000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1040610000.00
PLRX cash_flow (annual, 2025-12-31) — Amortization Of Securities: 3956000.00
PLRX cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: 282000.00